FIG. 3.

Progression and survival by response to treatment. Kaplan–Meier curves demonstrating the survival in years by response at 3 months after isolated limb infusion for responders (complete response and partial response) compared with nonresponders (stable disease and progressive disease) for patients with a melanoma in-field progression-free survival; b melanoma distant metastatic-free survival; c melanoma overall survival; d sarcoma in-field progression-free survival; e sarcoma distant metastatic-free survival; and f sarcoma overall survival